These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
270 related items for PubMed ID: 12015454
1. The relationship of Campylobacter jejuni infection and the development of Guillain-Barré syndrome. Tsang RS. Curr Opin Infect Dis; 2002 Jun; 15(3):221-8. PubMed ID: 12015454 [Abstract] [Full Text] [Related]
2. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome. Koga M, Takahashi M, Masuda M, Hirata K, Yuki N. Neurology; 2005 Nov 08; 65(9):1376-81. PubMed ID: 16162859 [Abstract] [Full Text] [Related]
7. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome. Yuki N. Cell Mol Life Sci; 2000 Apr 08; 57(4):527-33. PubMed ID: 11130452 [Abstract] [Full Text] [Related]
8. A way out of the maze: Campylobacter jejuni gene polymorphisms define Guillain-Barré syndrome. Wokke JH, van den Berg LH. Neurology; 2005 Nov 08; 65(9):1350-1. PubMed ID: 16275819 [No Abstract] [Full Text] [Related]
9. Campylobacter jejuni cst-II polymorphisms and association with development of Guillain-Barré syndrome. Hye JB, Nachamkin I. Neurology; 2007 May 08; 68(19):1633-4. PubMed ID: 17485654 [No Abstract] [Full Text] [Related]
10. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome? Kuwabara S, Ogawara K, Misawa S, Koga M, Mori M, Hiraga A, Kanesaka T, Hattori T, Yuki N. Neurology; 2004 Aug 10; 63(3):529-33. PubMed ID: 15304587 [Abstract] [Full Text] [Related]
15. Is Campylobacter lipopolysaccharide bearing a GD3 epitope essential for the pathogenesis of Guillain-Barré syndrome? Yuki N, Koga M, Hirata K. Acta Neurol Scand; 2000 Aug 27; 102(2):132-4. PubMed ID: 10949532 [Abstract] [Full Text] [Related]
18. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients. Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, Tio-Gillen AP, Van den Braak N, Jacobs BC, Van Doorn PA. Infect Immun; 2002 Mar 27; 70(3):1202-8. PubMed ID: 11854201 [Abstract] [Full Text] [Related]
19. A novel link between Campylobacter jejuni bacteriophage defence, virulence and Guillain-Barré syndrome. Louwen R, Horst-Kreft D, de Boer AG, van der Graaf L, de Knegt G, Hamersma M, Heikema AP, Timms AR, Jacobs BC, Wagenaar JA, Endtz HP, van der Oost J, Wells JM, Nieuwenhuis EE, van Vliet AH, Willemsen PT, van Baarlen P, van Belkum A. Eur J Clin Microbiol Infect Dis; 2013 Feb 27; 32(2):207-26. PubMed ID: 22945471 [Abstract] [Full Text] [Related]
20. Sensory Guillain-Barré syndrome after Campylobacter jejuni infection. Rajabally YA, Kass-Hout T, Wilson P, Damian MS. Eur J Neurol; 2007 Mar 27; 14(3):e11-2. PubMed ID: 17355531 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]